Sermorelin is the primary topic on Retapedia for the
terms listed below. This page distinguishes other meanings and
related entries.
Sermorelin (also called GHRH (1-29), GRF 1-29, Geref, Sermorelin acetate) may refer to:
Primary topic
- Sermorelin — Stimulates the pituitary to release growth hormone and IGF-1 under normal feedback control. FDA-approved for GH deficiency; used off-label for anti-aging via nightly injection.
Also known as
The following names are catalogued aliases for the primary topic:
- GHRH (1-29)
- GRF 1-29
- Geref
- Sermorelin acetate
Related entries on Retapedia
- CJC-1295 — Raises growth hormone 2-10 fold and IGF-1 for over a week per injection. Weekly subcutaneous dosing. Investigational only; cardiovascular risks and product-quality concerns.
- Growth hormone — A 191-amino-acid peptide hormone from the anterior pituitary that stimulates growth and IGF-1 production. Prohibited under WADA as a performance enhancer.
External meanings
The term GHRH (1-29) may carry meanings outside this catalogue — for example, as a developmental code shared with an unrelated chemical entity, or as a trademarked product name in a different therapeutic area. Retapedia does not catalogue non-peptide compounds; consult an external reference such as PubChem or Wikidata for broader coverage.
Categories:
Disambiguation pages